Expand ITCI Menu
ITCI MENU

ITCI Stock Summary and Trading Ideas (Intra-Cellular Therapies | NASDAQ:ITCI)

Charts for Today's Stock Price and Implied Volatility in Intra-Cellular Therapies

19-Apr-2024

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ITCI by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Intra-Cellular Therapies (ITCI) Frequently Asked Questions

What does Intra-Cellular Therapies do?

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

What symbol and exchange does Intra-Cellular Therapies stock trade?

Intra-Cellular Therapies trades on the NASDAQ stock market under the symbol ITCI.

What is Intra-Cellular Therapies stock price doing today?

As of April 19, 2024, ITCI stock price climbed to $72.37 with 1,847,691 million shares trading.

What is Intra-Cellular Therapies's Beta?

ITCI has a beta of 1.00, meaning it tends to be less sensitive to market movements. ITCI has a correlation of 0.13 to the broad based SPY ETF.

How much is Intra-Cellular Therapies worth?

ITCI has a market cap of $7.05 billion. This is considered a Mid Cap stock.

How much money does Intra-Cellular Therapies make?

Last quarter Intra-Cellular Therapies reported $132 million in Revenue and -$.30 earnings per share. This fell short of revenue expectation by $-5 million and exceeded earnings estimates by $.13.

What is the highest and lowest price Intra-Cellular Therapies traded in the last 3 year period?

In the last 3 years, ITCI stock traded as high as $84.89 and as low as $28.40.

What are the top ETFs holding Intra-Cellular Therapies?

The top ETF exchange traded funds that ITCI belongs to (by Net Assets): VTI, VB, IWM, VXF, VBK.

Is Intra-Cellular Therapies (ITCI) a good investment?

ITCI stock has underperformed the market in the last year with a return of +16.4%, while SPY returned +21.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ITCI shares. However, ITCI has outperformed the market in the last 3 month and 2 week periods, returning +10.6% and +5.7%, while SPY returned +3.0% and -4.5%, respectively. This indicates ITCI has been having a stronger performance recently.

What is the support and resistance for Intra-Cellular Therapies (ITCI) stock price?

ITCI support price is $70.14 and resistance is $73.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ITCI stock will trade within this expected range on the day.